BPA for albuminex. Base year with four one-year option periods

Active Awarded Last action

Contract number
36E79722A0016
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 91% complete
IDV ceiling
$1,125,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This Blanket Purchase Agreement, awarded by the National Acquisition Center (NAC) on April 5, 2022, establishes a single-award vehicle with a ceiling value of $1,125,000 for the procurement of ALBUMINEX albumin products. The prime contractor is Bio Products Laboratory LIMITED (UEI: ZMT1KZGKDCX3), an international pharmaceutical manufacturer specializing in albumin and related blood products. The contract operates under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has no set-aside restrictions. The contract structure includes a base year with four one-year option periods, extending through April 4, 2027, with exercise of the fourth option year confirmed under contract number 36E79722A0016. This procurement supports the Department of Veterans Affairs' medical operations by enabling efficient acquisition and distribution of albumin products to Veterans Affairs medical facilities nationwide.

The albumin products procured under this vehicle serve critical therapeutic purposes within the Veterans Health Administration's hospital and clinical settings, where albumin is utilized for plasma volume expansion, wound healing support, and treatment of hypoproteinemia and other medical conditions. As a component of the Pharmaceuticals and Drugs schedule, this agreement provides the Department of Veterans Affairs with streamlined ordering procedures and pre-negotiated pricing for albumin procurement, eliminating the need for individual competitive solicitations for each requirement. The five-year performance period and multiple option-year structure provide supply continuity for VA medical facilities while managing pharmaceutical inventory and ensuring reliable access to this essential product for veteran patient care.

Transactions

Action Obligated Date
Exercise an Option P00008 · Exercise option year 4 - BPA 36E79722A0016 $0
Supplemental Agreement for work within scope P00007 · 2026 public law pricing updates. $0
Exercise an Option P00006 · This modification is issued to exercise option year 3 on BPA 36E79722A0016. $0
Supplemental Agreement for work within scope P00005 · 2025 public law pricing updates $0
Exercise an Option P00004 · This modification is issued to exercise option year 2 on BPA 36E79722A0016. $0
Supplemental Agreement for work within scope P00003 · This modification is issued to incorporate 2024 public law updates to BPA 36E79722A0016. $0
Exercise an Option P00002 · Exercise option year 1 on BPA 36E79722A0016 $0
Supplemental Agreement for work within scope P00001 · 2023 public law pricing updates $0
Original award $0

Quick answers

Who was awarded contract 36E79722A0016?

36E79722A0016 was awarded to Bio Products Laboratory LIMITED by National Acquisition Center (Headquarters) on April 5, 2022.

How much is contract 36E79722A0016 worth?

36E79722A0016's own ceiling is $1,125,000.

Who can order from contract 36E79722A0016?

36E79722A0016 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79722A0016 under another contract?

Yes. 36E79722A0016 is a blanket purchase agreement under 36F79722D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79722A0016 competed?

The extent of competition for 36E79722A0016 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV